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Sample preparation is a crucial part of chemical analysis and in most cases can 3 
become the bottleneck of the whole analytical process. Its adequacy is a key factor in 4 
determining the success of the analysis and, therefore, careful selection and 5 
optimization of the parameters controlling sample treatment should be carried out. This 6 
work revises the different strategies that have been developed for sample preparation 7 
prior to capillary electrophoresis-mass spectrometry (CE-MS). Namely, the present 8 
work presents an exhaustive and critical revision of the different samples treatments 9 
used together with on-line CE-MS including works published from January 2000 to July 10 
2006. 11 
 12 
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1 Introduction. 1 
 2 
It is generally assumed that in order to provide an adequate chemical analysis 3 
any analytical method must include the following steps: sampling (sample must be 4 
representative of the object under investigation), sample preservation (sample should be 5 
kept stable until the analysis in completed), sample preparation, sample analysis per se 6 
and data treatment. Often, one of the the bottlenecks of this analytical process is sample 7 
preparation since it is usally a time-consuming and laborious step. The purpose of any 8 
sample preparation is the clean-up of the sample and/or the extraction, enrichment or 9 
preconcentration of the analytes, improving in this way the quality of the analytical 10 
results obtained. However, it has to be considered that any sample treatment will depend 11 
on both the sample nature and the following analytical technique that is going to be 12 
employed, requiring an almost case-by-case development. Therefore, no universal 13 
sample preparation is available. 14 
The choice and optimization of a suitable sample pretreatment is not easy, 15 
especially with highly complex sample matrices like biological fluids (plasma, serum, 16 
whole blood, urine, etc.) or other natural matrices including e.g., foods, plant extracts or 17 
environmental samples. Ideally, sample preparation should be as simple as possible, not 18 
only because it will reduce the time required, but also because the greater the number of 19 
steps, the higher the probability of introducing errors. If possible, sample preparation 20 
should be carried out without loss of the analytes (or with the minimum loss) while 21 
eliminating as many interferences as possible from the matrix. Finally, it should also 22 
include, when necessary, a suitable dilution or concentration of the analytes in order to 23 
obtain an adequate concentration for the subsequent analysis. Sometimes, it may also 24 
include the transformation of the analytes into different chemical forms that can make 25 
5 
easier e.g., their separation or detection. 1 
At the present time, developments in sample pretreatment strategies involve the 2 
use of new extraction materials, the use of automated protocols and/or its integration 3 
into miniaturized formats such as microchips or micrototal analysis sytems (µ-TAS) that 4 
should allow a rapid and sensitive analysis of the target analytes, especially in complex 5 
samples [1]. This research area has provided interesting and promising results and it 6 
will surely be one of the working areas in the future Analytical Chemistry. 7 
 Nowadays, the inherent advantages of the use of capillary electrophoresis (CE) 8 
as separation technique are well known and can be summarized in high separation 9 
efficiency, low analysis time, high resolution power and low consume of samples and 10 
reagents. It is at the moment one of the premier analytical separation techniques for the 11 
analysis of biological compounds such as peptides, proteins and polynucleotides and 12 
has been applied with success to a great variety of analytes [2-6]. Its different separation 13 
modes (CZE, MEKC, ITP, etc.) have allowed facing the problem of the separation of 14 
either neutral or charged analytes based on different physico-chemical properties 15 
(charge/mass ratio, molecular weight, polarity or isoelectric point). Besides, the 16 
different detectors available (UV-Vis, laser induced fluorescence (LIF), mass 17 
spectrometry (MS), electrochemical, etc.) have also broadened its use and applications, 18 
although UV is the most widely used detector in CE equipments so far. 19 
Nevertheless, the small capillaries used in CE separations accommodate only 20 
small volumes of sample, which require either the use of a suitable on-line or off-line 21 
preconcentration procedure or the use of a more sensitive detector like LIF or MS. In 22 
this regard, MS gives information on the molecular weight of the analytes and enables 23 
the separation of co-migrating molecules increasing selectivity and specificity acting as 24 
a second dimension. Furthermore, it also compensates the migration time variation that 25 
6 
normally takes place in CE and provides unequivocal structural information via 1 
fragmentation patterns that can be obtained for instance via MSn procedures. Therefore, 2 
the on-line coupling of CE with MS gives rise to an impressive analytical tool that 3 
combines the high resolution power and separation speed of CE with the high sensitivity 4 
and selectivity of the mass spectrometer [4, 7, 8]. However, in order to take advantage 5 
of the many possibilities derived from using CE-MS, it is of extreme importance a 6 
suitable selection of CE separation parameters (buffer composition, pH, 7 
preconcentration procedures), ionization technique (usually electrospray, ESI), and ESI 8 
and MS working parameters.  9 
Thus, when developing a suitable CE-MS procedure several aspects have to be 10 
taken into account. Only highly volatile buffers can be used and they are tipically an 11 
aqueous or hydroorganic solution containing e.g., acetic acid, formic acid, ammonium 12 
hydroxide at low concentrations. The use of non volatile components like cyclodextrins 13 
(CDs), inorganic salts (e.g., containing sodium, phosphate, etc) or surfactants (as SDS) 14 
are precluded since they are strong inhibitors of ESI efficiency, increase the noise and 15 
reduce the sensitivity of the system. Different strategies have been proposed to 16 
overcome this limitation including the partiall filling technique [9]. 17 
An additional consideration prior to use CE-MS is the development of suitable 18 
sample pretreatment procedures [10]. As an example, direct injection of samples with a 19 
high protein content results in short capillary longevity (proteins precipitate and can 20 
irreversibly adsorb onto the silanol groups of the internal capillary wall) [11]. 21 
Furthermore, despite the selectivity of the mass spectrometer, highly complex samples 22 
may also induce some ionization suppression or even a complete loss of the MS signal. 23 
The objective of this work is, therefore, to provide an overview of the various samples 24 
preparation protocols that have recently been proposed prior to on-line CE-MS covering 25 
7 
relevant publications from January-2000 till July-2006. 1 
 2 
2. Sample treatments. 3 
 4 
 In the time covered by the present review, different and interesting sample 5 
treatments prior to CE-MS have been proposed, which are sumarized in Table 1. As will 6 
be next discussed, in some occasions a single or simple treatment procedure was not 7 
enough to ensure the correct analysis of the sample, requiring the use of several 8 
consecutive sample treatments. In other cases, a single extraction or preconcentration 9 
procedure was enough to reduce the sample complexity or to improve the LODs 10 
achieved by CE-MS.  11 
 12 
2.1 Liquid-liquid extraction (LLE). 13 
 14 
This classical sample treatment allows the extraction of both trace analytes or 15 
macrocomponents. The selectivity and efficiency of the extraction process in LLE 16 
depends mainly on the election of the immiscible solvents, but other factors may also 17 
affect the distribution of the solute into both phases like the pH, the addition of a 18 
complexation agent, the addition of salts (salting out effect), etc. Although the use of 19 
LLE alone provides goods results in terms of extraction efficiency and clean-up of the 20 
samples, it is often carried out in combination with other preconcentration procedures as 21 
it will clearly be seen in the subsequent examples and sections. 22 
Rudaz et al [12] developed a CE-MS stereoselective analysis of tramadol and its 23 
main phase I metabolite in plasma after LLE with hexane-ethyl acetate (80:20, v/v); 24 
samples were evaporated and redissolved in 0.01 M HCl. The best enantioseparation 25 
8 
was achieved using a coated polyvinyl alcohol (PVA) capillary and a 40 mM 1 
ammonium acetate buffer at pH 4.0 with 2.5 mg/ml sulfobutyl ether β-CD as the chiral 2 
selector. To avoid the entrance of the CDs in the MS and, as a result, the loss of the MS 3 
signal, the partial filling technique was applied.  4 
Strickmann et al [13] developed an on-line capillary electrochromatography 5 
(CEC)-ESI-MS method for the determination of etodolac and metabolites in urine. 6 
CEC, although difficult to perform, is together with CZE the preferred CE mode for on-7 
line coupling with MS, because of the highly volatile buffers frequently used. The drug 8 
and metabolites in urine could be analyzed by CEC-ESI-MS after LLE extraction using 9 
an equal volume of ethyl-acetate and then evaporated and redissolved into the 10 
separation buffer.  11 
Wey et al [14] have developed a CE-ESI-MS method for the analysis and 12 
confirmation testing of morphine and related opioids in human urine by using a BGE 13 
containing 25 mM ammonium acetate at pH 9. High analyte concentrations (2-5 µg/ml) 14 
could be monitored in plain and diluted urine samples without further treatment directly 15 
by CE-MS. However, for the recognition of lower concentrations LLE at alkaline pH 16 
and solid phase extraction (SPE) were used and compared. Concerning the LLE 17 
procedure, a mixture of dichloromethane and dichloroethylene was used as extraction 18 
solvent. Mean recovery values ranged between 76 and 86% except for the metabolites 19 
nordihydromorphine and normorphine which were 14 and 25% respectively. However, 20 
the SPE procedure using a mixed mode polymer phase (namely, Bond Elut and Vac-21 
Elut) provided higher recoveries, between 83 and 96% for all the compounds. For this 22 
particular application, SPE was shown to be more time consuming than LLE since an 23 
additional evaporation step was required to eliminate water from the eluate. 24 
 25 
9 
2.2 Solid-phase extraction (SPE). 1 
 2 
Sample preparation using SPE was firstly introduced in the mid-1970s, replacing 3 
LLE due to its simplicity, selectivity and the better LODs that it provides. Since then, 4 
SPE has gained a wide acceptance due to the ease of automation, high analyte recovery, 5 
extraction reproducibility, ability to increase selectively analyte concentration and 6 
commercial availability of many SPE devices and sorbents, including the use of 7 
molecular imprinted polymers (MIPs) [15, 16]. 8 
Concerning the use of SPE it is probably the most widely used sample 9 
pretreatment procedure prior to CE-MS. Recently, Hernández-Borges et al [17] have 10 
determined five triazolopyrimidine sulfoanilide herbicides (cloransulam-methyl, 11 
diclosulam, florasulam, flumetsulam and metosulam) in soy milk by SPE-CZE-MS 12 
using C18 cartridges. For this purpose, CE-UV and CE-MS instruments were used. To 13 
increase the sensitivity of the method, normal stacking mode (NSM) was also used for 14 
on-line preconcentration of the SPE extract, providing LODs down to 74 µg/L. Mean 15 
recovery percentages ranged between 40 and 94% with good separations when working 16 
with aqueous solutions and SPE-NSM-CE-UV as shown in Figure 1A. However, the 17 
use of SPE combined with NSM-CZE-UV for analysis of the mentioned pesticides in 18 
soy milk did not provide suitable results because of the high number of interferences 19 
from the sample matrix (see Figure 1B). In order to overcome this limitation CE-MS 20 
was used. Thus, the main ESI-MS parameters (nebulizer pressure, dry gas flow rate, dry 21 
gas temperature and sheath-liquid composition) were optimized by means of a central 22 
composite design. Optimum separation buffer was composed of 24 mM formic acid and 23 
16 mM ammonium carbonate at pH 6.4, while the sheath-liquid was composed of 24 
acetonitrile:water 82.5:17.5 (v/v) with 2% of TEA at 0.35 mL/h flow rate. The 25 
10 
combined use of SPE-NSM-CE-MS allowed the detection of these pesticides in soy 1 
milk as can be seen in Figure 1C.  2 
Peterson et al [18] developed a specific CE-ESI-TOF-MS method for the 3 
determination of serotonin (5HT) and its precursos tryptophan (Trp) and 5-4 
hydroxytryptophan (5HTP) in human platelet rich plasma. Analytes were removed from 5 
the plasma and preconcentrated by SPE using Oasis MCX columns with mean 6 
recoveries between 71.6 and 95.3%. Submicromolar LODs were obtained for standard 7 
mixtures of all the compounds except for 5HTP which had LODs in the low micromolar 8 
range. When the method was applied to the analysis of plasma extracts from healthy 9 
volunteers as well as from pathological samples the levels of both 5HT and Trp were 10 
determined while 5HTP was not found present in any of the samples. In a previous 11 
work of the same group [19] also a CE-ESI-TOF-MS method was used for the 12 
determination of catecholamines (dopamine, norepinephrine and epinephrine) and their 13 
O-methoxylated metabolites (3-methoxytyramine, normetanephrine, metanephrine) in 14 
urine. In this case the capillary was coated with polyvinyl alcohol and the injection of 15 
the samples was carried out electrokinetically. Catecholamines and metanephrines were 16 
removed from the urine samples and preconcentrated by SPE using cation-exchange 17 
sorbents (Oasis MCX) with mean recovery values over 80% for all the analytes, except 18 
for epinephrine (75%).  19 
Vuorensola et al [20] have also analyzed eight catecholamines in aqueous and 20 
alcoholic (ethanol, methanol and 1-propanol) non-aqueous solutions by CE-MS but in 21 
this case using sheathless nanospray coupling. A comparison was made between 22 
different separation electrolytes for the separation of these compounds. Although non-23 
aqueous media (in methanol) was more efficient than water, both methods were applied 24 
to the analysis of urine samples extracted with Oasis HLB cartridges using a previously 25 
11 
developed protocol [21]. The sensitivity of the non-aqueous nanospray method (0.48-1 
1.30 µM) was only slightly better than that of a previous aqueous method using coaxial 2 
sheath-liquid coupling [22]. 3 
SPE procedures are often used after the LLE or solid-liquid extraction of the 4 
analytes assisted or not by ultrasounds, microwaves, etc. Rodríguez et al [23] have used 5 
C8 cartridges for the extraction of pesticides thiabendazole and procymidone from fruits 6 
(apples, grapes, oranges, pears, strawberries) and vegetables (tomatoes) after a suitable 7 
sonication of the homogenized samples with methanol:water 1:1 for 15 min. Separation 8 
was achieved using a buffer of formic acid-ammonium formate at pH 3.5 with 2% of 9 
methanol (the sheath-liquid was the same as the separation buffer). LOQs of the SPE-10 
CE-MS procedure (using also a stacking technique) ranged between 0.005 and 0.05 11 
mg/kg, with mean recovery values of 64 and 75% for thiabendazole and procymidone, 12 
respectively.  13 
Recently, Juan-García et al [24] have also extracted six pesticides 14 
(thiabendazole, pyrifenox, pirimicarb, pyrimethanil, procymidone and dinosed) from 15 
peaches and nectarines with a mixture water:acetone 1:1 (v/v) prior to their SPE 16 
extraction with C18 cartridges before their CE-MS or CE-MS/MS determination. In this 17 
case, a buffer consisting of 0.3 M ammonium acetate-acetic acid pH 4 in 10% methanol 18 
(the sheath-liquid had the same composition) was used. Recovery percentages ranged 19 
between 58 and 99% with relative standard deviation values (RSD %) between 9 and 20 
19%. Under optimized CE-MS/MS conditions the minimum detectable levels of the six 21 
pesticides in spiked samples were between 0.01 and 0.05 mg/kg.  22 
Sentellas et al [25] described the optimization of a clean-up and preconcentration 23 
procedure for the determination of fifteen heterocyclic amines in human urine samples. 24 
In this work, Oasis MCX and LiChrolut TSC cartridges were studied by using UV 25 
12 
detection. Peak intensities obtained after clean up for both sorbents were similar for 1 
most of the amines; however, Oasis MCX cartridges were selected because they 2 
provided slightly better recoveries for some of the amines. When urine samples were 3 
analyzed, interferences preventing the analytes identification were observed with both 4 
cartridges, that is why a LLE procedure using dichloromethane was used. The 5 
optimized clean-up procedure together with a previously published field-amplified 6 
sample injection (FASI)-CE-MS method [26] was used for the quantification of 7 
heterocyclic amines in hydrolyzed spiked human urine, obtaining LOD down to 0.3 8 
ng/mL. 9 
As it has been previously indicated, BGE solutions as well as sheath-liquid 10 
compositions should be volatile enough in CE-MS. In spite of this limitation, several 11 
works have appeared in which CDs are used as components of the separation electrolyte 12 
to analyze SPE extracts by CE-MS [27-29]. For instance, Servais et al [29] have used 13 
nonaquous CE (NACE)-ESI-MS with heptakis(2,3-di-O-acetyl-6-O-sulfo)-β-14 
cyclodextrin (HDAS-β-CD) in the BGE for the enantioselective determination of low 15 
concentrations of salbutamol in SPE extracts from human urine. The selected separation 16 
electrolyte consisted of 10 mM ammonium formate and 15 mM HDAS-β-CD in 17 
methanol acidified with 0.75 M formic acid. This approach was applied to the 18 
quantitative determination of salbutamol enantiomers in human urine after SPE using 19 
Isolute HCX-3 cartridges. The SPE-NACE-MS allowed the determination of both 20 
compounds at concentrations ranging from 8 to 14 ng/mL. 21 
 22 
2.3 Solid-liquid extraction. 23 
 24 
 Extraction from solid matrices has to be carried out after an adequate 25 
13 
homogenization or trituration of the sample, which can be enhanced (as well as the 1 
extraction efficiency) by lyophilization or by the use of liquid-nitrogen. The extraction 2 
of organic compounds, for example, involve the desorption of the analytes from the 3 
sample matrix and their later dissolution into the solvent, which is controlled by the 4 
solubility, mass transfer and matrix effects. Extraction can be improved by either 5 
assisting the process with ultrasounds, microwaves, etc. Sonication, for example, helps 6 
in the homogenization of the sample and, consequently, it can be used for the rapid an 7 
easy extraction of analytes from solid samples. Thus, Groom et al [27] have analyzed 8 
nitroaromatic and cyclic nitramine contaminants originated from military explosives 9 
and propellants (TNT, TNB, RDX, HMX, CL-20) in soil and marine sediments using 10 
sonication with acetonitrile together with sulfobutylether-β-cyclodextrin (SB-β-CD) 11 
assisted CE-ESI-MS. In this work, it was also stated that the presence of highly charged 12 
SB-β-CDs may affect the identification of target explosive analytes. Optimum BGE 13 
consisted of 10 mM SB-β-CD and 10 mM ammonium acetate at pH 6.9 using 14 
acetonitrile alone as sheath-liquid.  15 
Feng et al [30] have analyzed several alkaloids (aconitine, hypaconitine, 16 
mesaconitine, brucine, strychnine, icajine, atropine, novacine) and their hydrolysis 17 
products in Chinese medicine preparations (Maqianzi, the seed of Strychnos pierrian , 18 
and Wutou, aconite root of Radix aconiti praeparata) by CE-ESI-MS. Pulverized 19 
samples were immersed in methanol overnight and afterwards ultrasonicated for 30 min 20 
prior to their CE-MS determination. Goodwin et al. [31] were able to separate and 21 
determine herbicides glyphosate and glufosinate and their derivatives 22 
(aminomethylphosphonic acid and methylphosphinicpropionic acid) in wheat samples 23 
using CE-ESI-MS with a sheathless interface. In this case wheat samples were extracted 24 
in a mixture of water-acetone 1:1 with magnetic stirring for 1 h. The separation buffer 25 
14 
was 1 mM ammonium acetate/acetic acid at pH 6.3 in a mixture methanol:water (50:50, 1 
v/v). The best reproducibility in terms of migration times and peak areas was obtained 2 
using a capillary coated with linear polyacrilamide. The extract was directly injected in 3 
the CE system and the final LOD was 1 µM in water and 2.5 µM in the wheat water-4 
acetone extract. 5 
Suomi et al [32] determined five neutral irioid glycosides (cyclopentanol 6 
monoterpene derivatives) in plant samples by micellar electrokinetic chromatography 7 
(MEKC) using SDS as surfactant. The separation system was coupled via a coaxial 8 
sheath-liquid flow ESI interface to a MS using the partial filling (PF) technique to avoid 9 
the entrance of the micelles in the MS. The separation, which was optimized by MEKC-10 
UV, was achieved by using a BGE consisting of 100 mM SDS in 20 mM ammonium 11 
acetate at pH 9.5 (Figure 2). The compounds were detected as lithium adducts by the 12 
addition of 1.0 mM lithium acetate to the sheath-liquid (water-methanol 50:50, v/v). 13 
The extraction of the samples was carried out with boiling water for 60 min of the 14 
crushed dry leave samples (after 40 min at room temperature to wet the leaves 15 
throughly), and after evaporation to dryness, the extract was redissolvend in Milli-Q 16 
water and injected in the CE system. Catalpol, verbenalin, loganin and possibly 10-17 
cinnamoyl catalpol were found in the examination of seven plants species in the genera 18 
Plantago, Veronica, Melampyrum, Succisa and Valeriana. LODs for the iridoid 19 
glycosides ranged were 25 mg/L except for catalpol which was 50 mg/L. In a second 20 
work by the same group, Suomi et al [33] separated a higher number of irioid 21 
glycosides (eleven) in several plants belonging also to the genera Plantago, Veronica, 22 
Melampyrum, Succisa and Valeriana by PF-MEKC-ESI-MS. In this case, extraction of 23 
the dry leave samples was also carried out with boiling water for 60 min. 24 
Recently, Arráez-Román et al [34] have tested different liquid-phase extraction 25 
15 
procedures to establish which could provide the highest content of polyphenols and 1 
bitter acids from hop characterized by CE-MS (optimum BGE was 80 mM ammonium 2 
acetate at pH 10.5). For this purpose hop pellets were powdered and extracted with 3 
different solvents like hexane, methanol, methanol:water, etc. by shaking. Among them, 4 
the extraction with hexane to remove lipids, carotenoids and chlorophylls and later with 5 
methanol (to extract sugars, organic acids and phenolic compounds) allowed the 6 
detection of the highest number of compounds.  7 
Juan-García et al [35] determined five quinolone residues (danofloxacin, 8 
enrofloxacin, flumequine, ofloxacin and pipemidic acid) in chicken and fish by CE-MS 9 
by solvent extraction of the minced muscle tissues. A sodium phosphate buffer at pH 10 
7.0 was added to the spiked samples which were later extracted with dichloromethane 11 
(rotary shaking). The organic layers were then extracted with 0.5 M NaOH. This 12 
aqueous phase was adjusted to pH 7 and extracted with hexane to eliminate the fat and it 13 
was then passed through a C18 cartridge following a suitable SPE protocol. Mean 14 
recovery values of the whole procedure ranged between 45 and 99% for chicken 15 
samples and between 52 and 90% for fish samples. The proposed method is sufficiently 16 
sensitive to analyse these quinolone in both samples because the LOQs achieved (50 17 
ng/g) were below the maximum residue limits (100-200 ng/g) established by the EU. 18 
 19 
2.4 Solid-phase microextraction (SPME). 20 
 21 
SPME was firstly developed by Pawliszyn and co-workers in 1989 and became 22 
commercially avaible in 1993 [36]. Since its development, SPME has been increasingly 23 
used since its setup is small and convenient, it can be used to extract analytes from very 24 
small samples, it provides a rapid extraction and transfer to analytical instrument and 25 
16 
can be easily combined with other extration and/or analytical procedures improving in a 1 
large extent the sensitivity and selectivity of the whole method. 2 
The on-line coupling of SPME with CE has been described in several occasions 3 
[37, 38], however, the use of such coupling is still a non-resolved topic because of the 4 
very small injection volumes required in CE. As a result, SPME-CE analyses are 5 
typically carried out in an off-line mode, by manually desorbing the analytes in an 6 
appropriate organic solvent, and later introducing it into the CE system. Rodríguez et al. 7 
[39] carried out the analysis of a group of pesticides (ioxynil, o-phenylphenol, 8 
haloxyfop, acifluorfen, picloram) in fruit samples by using SPME prior to CE-MS. In 9 
that work, the buffer used consisted of 32 mM HCOONH4/HCOOH at pH 3.1 while the 10 
sheath-flow was made of 32 mM separation buffer with a 20 % of methanol with 14 11 
µL/min flow. After testing different SPME fibers, the use of CW-TPR allowed the 12 
extraction of these pesticides from water and fruit samples down to 0.02-5 mg/kg 13 
(LOQ).  14 
Hernández-Borges et al. [40] tested different SPME fibers and CE-MS for the 15 
extraction and quantitative determination of a group of pesticides (pyrimethanil, 16 
pyrifenox, cyprodinil, cyromazine and pirimicarb) in orange and grape juices. The 17 
buffer used consisted of a volatile aqueous solution containing 0.3 M ammonium 18 
acetate/acetic acid at pH 4 while the sheath-liquid was made of a mixture 19 
isopropanol:water (65:35, v/v) at 0.22 ml/h flow. In this case, SPME parameters (e.g. 20 
extraction time, sodium chloride percentage, pH and desorption time) were optimized 21 
by means of a chemometrical approach. The best results were achieved by direct 22 
immersion of a PDMS-DVB fiber which allowed achieving LODs of these pesticides at 23 
concentrations down to 15 ng/mL in water samples and down to 40 ng/mL in fruit 24 
juices.  25 
17 
Other SPME modifications like stir-bar sorptive extraction (SBSE) [41] or fiber-1 
in-tube SPME [42] have not yet been combined with CE-MS. 2 
 3 
2.5 Pressurized liquid extraction (PLE).  4 
 5 
Pressurized liquid extraction (PLE), also called accelerated solvent extraction, is 6 
a sample preparation technique in which a solvent at elevated temperature and pressure 7 
is used as extractant. By adequately chosing the solvent, its temperature and pressure it 8 
is possible to control, among other factors, the dielectric constant of the extractant and 9 
with that the polarity of the compounds that can be obtained. Moreover, PLE works in 10 
an automatic way, it requires small amounts of solvents and low extraction times. 11 
Therefore, PLE can provide fast extractions and purifications allowing testing a high 12 
number of extraction conditions under controlled conditions. 13 
The possibilities of the combined use of PLE and CE-MS were recently 14 
demonstrated by Herrero et al [43-45]. PLE-CE-MS was applied to the extraction and 15 
characterization of the main antioxidants (i.e., polyphenols) from rosemary [43] and the 16 
extraction and characterization of phycobiliproteins from the microalga Spirulina 17 
platensis [44, 45]. In this latter case, a thorough optimization of both the PLE extraction 18 
conditions (including sonication of the sample prior to PLE) and CE-MS conditions had 19 
to be carried out, demonstrating that PLE-CE-MS can be a fast, automatic and highly 20 
informative method for natural products investigations [46]. 21 
 22 
2.6 Other procedures. 23 
 24 
Apart from the previosly described sample treatment procedures, Table 1 also 25 
18 
shows different and interesting alternatives for this purpose. Thus, introduced in the 1 
mid-nineteenth century, soxhlet extraction has been one of the extraction methods more 2 
used until the development of modern extraction techniques. The need of cooled, 3 
condensed solvents for the extraction makes this technique a slow alternative (up to 24-4 
48 hours of extraction) with a very high consumption of organic solvents that have to be 5 
evaporated, although with very high recoveries and also with multiple sample extraction 6 
possibilities. Concerning its combination prior to CE-MS several approaches have 7 
appeared [47-49]. Very recently, Edwards et al [48] have used soxhlet extraction in 8 
combination with LLE and SPE for the characterization by CE-ESI-MS of secondary 9 
metabolites (flavonoids) from the antihyperglycaemic plant Genista tenera. In this case, 10 
air-dried and powdered plants were extracted in a soxhlet apparatus with ethanol. After 11 
filtration and evaporation the residue was redissolved in water and extracted 12 
successively with diethyl ether, ethyl acetate and butanol. After another evaporation and 13 
redissolution of part of the extract a SPE procedure with C18 was carried out. Optimum 14 
buffer was composed of water:2-propanol (95:5, v/v) containing 10 mM ammonium 15 
carbonate at pH 9.25. The CE-MS study of the extract allowed the identification of five 16 
flavonoid aglycones, five flavonoid-monoglycosides, two flavonoid-diglycosides, one 17 
flavonoid-triglycoside, thee monoacetyl-flavonoids, one diacetyl-flavonoid and one 18 
acetyl-flavonoid-glycoside. Wahby et al [49] have also used soxhlet extraction for the 19 
extraction of atropine (tropane alkaloid) and choline (quaternary base) in hairy root 20 
cultures of Cannabis sativa L. Hairy root cultures were rinsed with tap and distilled 21 
water, frozen in liquid nitrogen and lyophilized. The dry material was ground to a fine 22 
powder and extracted in a soxhlet apparatus with 70% of aqueous methanol for 16 h. 23 
After cooling, the extracts were filtered and concentrated. Both compounds could be 24 
determined in the samples with LODs of 18 mg/L for choline and 320 µg/L for atropine 25 
19 
using a BGE of 20 mM ammonium acetate at pH 8.5 and a sheath-liquid composed of 1 
50:50, v/v 2-propanol:water with 0.5% (v/v) formic acid 0.18 mL/h. 2 
The combination of automated sample preparation in CE is especially useful for 3 
the analysis of complex samples [50] since it can improve the selectivity and sensitivity 4 
of the determination as well as to decrease the time involved in the sample treatment 5 
[50, 51]. One of the main lines of research in this area is the combination of flow 6 
injection systems with CE and, in a less extent, with CE-MS. Thus, Santos et al [52] 7 
reported a new method for the separation and detection of 9 biogenic amines by the 8 
used of a flow manifold coupled to a CE-ESI-MS for the automatic filtration of the 9 
samples and their insertion into the CE vials. The on-line filtration was carried out using 10 
a flow injection system coupled to the CE instrument. The BGE was composed of 25 11 
mM citric acid at pH 2.0. Two injection modes (hydrodynamic and electrokinetic) were 12 
tested. Although electrokinetic injection provided better sensitivity, it was also found to 13 
give worse precision and linear range and, therefore, hydrodynamic injection was 14 
selected. The method allowed the detection of amines between 0.018 and 0.09 µg/mL. 15 
The method was applied to the determination of biogenic amines in red and white wines 16 
with mean recovery values around 100%. 17 
The use of microwave radiation for sample pretreatment has attracted growing 18 
interest in the past few years and has yield a numerous amount of publications [53-56]. 19 
Microwave radiation provides a homegeneous and instant heating of the sample 20 
yielding into very quick and effective extraction/digestion and thus strongly decreasing 21 
sample pretreatment times. Van Lierde et al [57] used microwave-assisted acid 22 
digestion of porcine and human skin to extract chromium species from these samples. 23 
The mechanism of chromium transport through the skin and the relationship between 24 
chromium allergy and chromium species (in vitro permeation experiments) was studied. 25 
20 
For this purpose, CE-was used with inductively coupled plasma-mass spectrometry 1 
(ICP-MS) using a BGE composed of 50 mM phosphate buffer (pH 2.5). For the 2 
digestion of the samples, skin membranes were dried at 30ºC for 24 hours, after that 3 
HNO3 and H2O2 were added. Digestion was carried out at different microwave 4 
intensities for a total of 25 min. The LODs of the method ranged between 6 and 12 µg 5 
of Cr per liter. 6 
 7 
3 Microfluidic devices. 8 
 9 
Clearly, development and/or use of microchip-CE are not objectives of this 10 
paper, however, microchip-CE devices deserve a special attention because they can 11 
automate sample preparation and, furthermore, they can integrate this step together with 12 
the chemical analysis under a single format that may allow a ultrarapid and sensitive 13 
analysis of the target analytes [58]. However, at the moment most of the applied 14 
aproaches suffer from several limitations regarding their fabrication, manipulation or 15 
the LODs that can be achieved. This can explain the very low number of publications 16 
found showing the on-line coupling of microchip-CE with MS.  17 
A recent application of a microbead-packed polydimethylsiloxane (PDMS) 18 
microchip with an integrated electrospray emitter for sample pretreatment prior to 19 
sheathless ESI-TOF-MS was presented by Lindberg et al [59]. This system was applied 20 
for the desalting and enrichment of six neuropeptides from a physiological solution. 21 
Figure 3 shows a schematic picture of the PDMS microchip design used in that work. 22 
Electrical contact for the sheathless ESI was achieved by coating the integrated emitter 23 
with a conductive graphite powder after applying a thin layer of PDMS as glue. Both 24 
the coating and the bond of the PDMS structures were found to have a very good 25 
21 
durability (a continuous spray was obtained over 800 h). Another PDMS microfluidic 1 
system was previously developed by the same group [60] and applied to the analysis of 2 
peptides but in this case only sample injection, separation and ESI emitter structures 3 
were integrated in a single platform. As found in the literature, PDMS microchips with 4 
an integrated ESI-emitter have been fabricated using different principles [61-66]. As an 5 
example, Dahlin et al [62] presented a PDMS-based microchip for in-line SPE-CE with 6 
an integrated electrospray emitter tip coupled to a TOF-MS. The chip was fabricated in 7 
such a way that mixed PDMS was cast over steel wires in a mold. The removed wires 8 
defined 50 µm cylindrical channels where fused silica capillaries were inserted. The 9 
microchip was fabricated in a two-level cross design. In one of these channels 10 
hypercross-linked polystyrene beads acted as SPE sorbent for desalting. In this work, 11 
six-peptide mixtures at different concentrations were dissolved in physiological salt 12 
solutions and injected, desalted, separated and sprayed into the MS for the analysis. 13 
LODs were in the femtomole levels. 14 
Microfluidic devices have also been used for in-line digestion of proteins [67, 15 
68]. Wang et al [67] have proposed the use of a microfluidic device with a CE channel 16 
connected to a MS (via an ESI interface) which contains a digestion bed on a monolithic 17 
substrate to carry out the in-line protein digestion. The application of this device for the 18 
rapid digestion, separation and identification of proteins was demonstrated for melittin, 19 
cytochrome c and bovine serum albumin. The rate and efficiency of the digestion was 20 
related to the flow rate of the substrate solutions through the reactor. For cytochrome c 21 
and bovine serum albumin the digestion time was 3-6 min at room temperature, while 22 
for melittin was 5 s. Microdevices provide a convenient platform for automated sample 23 
processing in proteomic applications. 24 
 25 
22 
4 Use of stacking techniques in CE-MS. 1 
 2 
Although strictly speaking the use of stacking techniques (except on-line SPE) 3 
cannot be considered part of the sample treatment, we would like to include a brief 4 
comment here about the use of these techniques together with CE-MS. On-line 5 
preconcentration strategies based on sample stacking [69-71], sweeping [72] and/or 6 
solid-phase extraction (SPE) [73-75] have shown their usefulness for improving the 7 
limits of detection (LOD) achieved by CE. Concerning the use of these techniques 8 
together with CE-MS they are not easy to apply and, in some cases, their use is limited. 9 
For instance, many of these preconcentration strategies involve the use of CDs, 10 
surfactants, and other non-volatile compounds that are precluded in CE-MS or can 11 
affect the stability of the electrical circuit in CE-ESI-MS. For example, the use of 12 
stacking with matrix removal (SWMR) is not possible in CE-MS since there is not 13 
outlet vial necessary in this case to reverse the polarity and to eliminate the sample 14 
matrix. In Table 1 it can be observed that these techniques are not widely applied in CE-15 
MS. 16 
The use of the electrokinetic injection in the mode called field-enhancement 17 
sample injection (FESI) also called field-amplified sample injection (FASI) or field-18 
amplified sample stacking (FASS) is one of the most commonly stacking techniques in 19 
CE-MS, because, despite the presence of the siphoning effect that can take place, the 20 
sensitivity improvement can be high, although in this case only one type of charged 21 
analyte (cations or anions) can be introduced into the capillary [25, 26, 76-79]. 22 
Hernández-Borges et al [17] have used normal stacking mode (NSM) for the 23 
preconcentration of pesticides after their SPE extraction from soy milk samples. This 24 
technique is easy to apply because only a low conductivity matrix is required (which 25 
23 
can be achieved by the use of organic solvent) since focusing takes places due to the 1 
abrupt change in the local electric field between the sample matrix and the BGE. In this 2 
case, the stacking was achieved by injecting a high amount of the sample (up to 100 s at 3 
20 psi) dissolved in pure acetonitrile. This specific type of stacking is often called 4 
acetonitrile stacking  because of the good sensitivity improvement that the use of 5 
acetonitrile alone in the sample matrix has provided, which has also been observed by 6 
different authors [80-84].  7 
 8 
5 Conclusions and future outlook. 9 
 10 
Some current trends in the todays’ sample pretreatment area are expected to 11 
continue in the future as important research areas within this attractive field of 12 
Analytical Chemistry. This is the case for the search of new extraction materials 13 
including the development of molecular imprinted polymers (MIPs) to adsorb specific 14 
analytes mimicking for instance immunorecognition. These new extraction materials 15 
can play a definitive role in the development of completely automated analytical 16 
processes able to provide information on analyte composition and concentration without 17 
the intervention of the operator. In this regard, the integration of sample preparation 18 
devices into miniaturized formats (e.g., microchips, µ-TAS) seem to be a very atractive 19 
way to achieve this goal while increasing even more the throughput and analysis speed 20 
of these methods. These future procedures combined with on-line stacking techniques 21 
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Figure captions 1 
 2 
Figure 1.- NSM-CE-UV electropherogram of: A) a standard solution containing ca. 1 3 
mg/L of each pesticide and; B) a SPE extract from soy milk sample containing 200 µg/L 4 
of each pesticide. Injection: 60 s at 0.5 psi. Running electrolyte: 24 mM formic acid, 16 5 
mM ammonium carbonate at pH 6.4; Total length: 57 cm (50 cm effective length); 6 
Voltage: +23 kV; Temperature: 22ºC. (1) Metosulam; (2) Cloransulam-methyl; (3) 7 
Diclosulam; (4) Florasulam; (5) Flumetsulam. C) Extracted ion electropherograms of a 8 
soy milk sample containing 200 µg/L of each pesticide analyzed under SPE-NSM-CE-9 
ESI-MS optimized conditions. Redrawn from [17] with permission. 10 
 11 
Figure 2.- (a) An on-line PF-MEKC-ESI-MS electropherogram of the mass 12 
spectrometric data. The capillary was 80 cm long and applied voltage was +15 kV 13 
(current 10 µA). Sample was injected at 50 mbar pressure for 10 s. The electrolyte 14 
solution contained 20 mM ammonium acetate at pH 9.2 and a solution of 100 mM SDS 15 
was injected for 200 s at 50 mbar pressure. The sheath-liquid contained 1 mM lithium 16 
acetate dissolved in water-methanol (50:50 v/v) and it was pumped to the electrospray 17 
interface at 180 µL/min. Mass area of 100-600 m/z was scanned. (b) A PF-MEKC-UV 18 
electropherogram of the sample of (a). Compounds were detected at 20 cm. Peak 19 
assignments: (1) catalpol; (2) ketologanin; (3) verbenalin; (4) loganin; (7) 10-cinnamoyl 20 
catalpol. Reprinted from [32] with permission. 21 
 22 
Figure 3.- Schematic picture of the PDMS microchip design. A) Shows the microchip 23 
as mounted on the holder in front of the MS. Graphite coated emitter was placed 24 
between two brass plates (B) to which the high voltage was applied. Holder (C) was 25 
34 
mounted on an xyz-adjustable table for easy alignment of the microchip in front of the 1 
TOF-MS orifice. Reprinted from [59] with permission. 2 
 3 
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Table 1.- Some examples of sample treatments, analytes and matrices studied by CE-MS. 
Analyte Matrix Treatment Interface Analyzer Buffer Observations References 
Hops acids, oxidized 
derivatives and iso-α-
acids 
Beer, hops pellets Extraction 
(acetone/water) for 
hops pellets; SPE for 
beer 
ESI (sheath-liquid: 2-
propanol:water 50:50 v/v, 
0.1% TEA, 3 µL/min) 
IT 160 mM (NH4)2CO3-
NH4OH pH 9 
- [85] 
Glycoproteins Bovine proteins Microcon filtration, 
enzymatic 
deglycosilation 
ESI (sheath-liquid: 1% 
HOAc in 2-propanol:water 
1:1, 4 µL/min) 
IT, TOF Several buffers Coated capillary [86] 




ESI (sheath-liquid: 0.1% 
HCOOH in 50% MeOH, 3 
µL/min) 
IT 20/40/40 ACN/100 mM 
HCOONH4 pH 3/water 
v/v/v 
FASI. LOD: 10-9 M [79] 
Carbohydrates Urine - ESI (sheathless) QTOF 50 mM NH4Ac-32% NH3 
pH 11 and 12 
- [87] 
Glycopeptides Plasma Lyophilization, 
digestion 
ESI (sheath-liquid: 2-
propanol-water 1:1 v/v, 
0.4% HCOOH, 2.5 
µL/min) 
QIT 50 mM HCOONH4 pH 2.7; 
50 mM triethylammonium 
acetate pH 5.0; 50 mM 
HCOONH4 pH 8.0 




Tobacco-N-nitrosamines Rabbits’ serum SPE ESI (sheath-liquid: 
MeOH-water 50:50 v/v, 
0.5% formic acid, 10 
µL/min) 
IT 75 mM ammonium formate 
(pH 2.5) or citrate (pH 2.4) 
- [89] 
Cytokinins Coconut water SPE ESI (sheath-liquid: 0.3% 
formic acid in 50% v/v 
MeOH:water, 4 µL/min) 
IT 25 mM amonium 
formate/formic acid (pH 
3.4), 3% v/v ACN 
MS2, stacking, LOD: 
0.05-0.18 µM 
[84] 
Phenolic compounds Virgin olive oil SPE ESI (sheath-liquid: 2-
propanol:water 60:40 v/v, 
0.1% v/v TEA) 
IT 60 mM NH4OAc pH 9.5 
with 5% 2-propanol 








ESI (sheathless) TOF 25:75 v/v ACN:10 mM 
acetic acid 
Microchip; LOD: 20 
fmol 
[59] 
Chromium species Porcine and human skin Microwave assisted 
digestion 
ICP SF 50 mM phosphate buffer 
pH 2.5 
LOD: 6-12 µg/L [57] 
10B-BPA 
(boronophenylalanine) 





ESI (sheath-liquid: 5 mM 
NH4Ac in 50 % v/v 
MeOH- water, 10 µL/min) 
IT 0.5 M HCOOH LOD: 3 µM; use of 
HR-ICP-MS 
[91] 
Flavonoids Plant (Genista tenera) Soxhlet, LLE, SPE ESI (sheath-liquid: IT Water:2-propanol 95:5, v/v, MS2 [48] 
Tables
IPA:water 50:50 v/v, 0.5 
µL/min) 
10 mM ammonium 
carbonate (pH 9.25) 
Choline, atropine Hairy root cultures of 
Cannabis sativa L. 
Soxhlet ESI (sheath-liquid: 50:50 
v/v 2-propanol:water, 
0.5% v/v formic acid 0.18 
mL/h) 
IT 20 mM NH4OAc, pH 8.5 LOD: 18 mg/L 
(choline), 320 µg/L 
(atropine) 
[49] 
Polyphenols, bitter acids 
and oxidation products 
Hops Extraction with 
different solvents 
ESI (sheath-liquid: 60:40 
v/v, 2-propanol:water, 
0.1% TEA, 0.28 mL/h) 
IT 80 mM NH4OAc/NH4OH, 
pH 10.5 
Caracterization of the 
methanolic extract of 
hops 
[34] 
Quinolone residues Chicken, fish Solvent extraction, 
SPE 
ESI (sheath-liquid: 60 mM 
(NH4)2CO3, pH 9.2, 10 
µL/min) 
QIT 60 mM (NH4)2CO3, pH 9.2 MSn, LOD: 20 ng/g [35] 




ESI (sheathless) QTOF 0.1  M HCOOH in 




Isoquinoline alkaloids Herb(Fumaria officinalis) 
and phytopharmaceuticals 
Soxhlet, LLE, SPE, 
ultrasounds 
ESI (sheath-liquid: 
isopropanol-water 1:1 v/v, 
3µL/min.) 
IT ACN-MeOH 9:1  v/v, 60 
mM NH4OAc and 2.2 M 
HOAc 
MS2 [47] 
Antioxidants Rosmarinus officinalis L. PLE ESI (sheath-liquid: 2-
propanol-water 60:40 v/v, 
0.1% v/v TEA; 0.24 mL/h) 
IT 40 mM NH4OAc/NH4OH, 
pH 9 
- [43] 
Nitroaromatic and cyclic 
nitramines 
Soil and marine sediment ACN sonication ESI (sheath-liquid: 100% 
ACN, 6 µL/min) 
QIT 10 mM SB-β-CD-10 mM 
NH4OAc (pH 6.9) 
LOD: 0.025-0.5 mg/L [27] 
Caffeine and metabolites Urine SPE ESI (sheath-liquid: 
MeOH-water-HCOOH 
79.7:19.8:0.5 v/v/v, 0.5 
mL/min) 
Q 50 mM (NH4)2CO3, pH 
11 .0 
- [93] 
Pesticide residues Peaches and nectarines Solvent extraction, 
SPE 
ESI (sheath-liquid: 0,3 M 
NH4OAc-HOAc, pH 4, in 
10% MeOH, 5 µL/min) 
QIT 0.3 M NH4OAc-HOAc, pH 
4, in 10% MeOH 
MS3, LOQ: 0.001-0.2 
mg/kg 
[24] 
Salbutamol enantiomers Human urine SPE ESI (sheath-liquid: ACN-
water 75/25 v/v, 0.1% 
HCOOH, 2.5 µl/ min) 
IT 10 mM HCOONH4 and 15 
mM HDAS-β-CD in 
MeOH, 0.75 M HCOOH 
LOQ: 18-20 ng/mL [29] 
Methylenedioxy-derivates 
of amphetamine 
Urine SPE ESI (sheath-liquid: ACN-
water-HOAc 50:49.5:0.5) 





Pesticides Soy milk SPE ESI (sheath-liquid: 
ACN/water 82.5:17.5 v/v, 
2% TEA, 0.35 mL/h) 
IT 24 mM HCOOH and 16 
mM (NH4)2CO3, pH 6.4 
LOD: 74-150 µg/L [17] 
Phosphorylated and acidic Escherichia coli DH5-α Cell lisation ESI (sheathless) QIT 80% v/v 20 mM NH4OAc MS2 [95] 
metabolites in prokaryotes pH 9.5 and 20% v/v 2-
propanol 




ICP Q Ammonium pH 9.25 with 
2% v/v OFM anion-BT 
Study of the 
association of 




Polypeptides and proteins Urine SPE, lyophilization ESI (sheath-liquid: 30% 
MeOH, 0.5% HCOOH) 
TOF 30% MeOH, 0.5% 
HCOOH, 69.5% water 
Identification of 
protein pattern in 
Type 1  diabetics 
[97] 
Neuropeptides - SPE ESI (sheathless) TOF 25:75 ACN:10 mM HOAc PDMS microchip, 
LOD: 0.1  µg/ml 
[62] 
Polypeptides Human urine Ultrafiltration, SPE, 
lyophilization 
ESI (sheath-liquid: 30% 
v/v isopropanol, 0.4% v/v 
HCOOH, 2 µL/min) 
TOF 20 % ACN, 0.25 M 









Culture broth of 
Trichoderma viride  
Preparative HPLC ESI (sheath-liquid: 2-
propanol:water 1:1 v/v; 
1% HCOOH; 4 µL/min) 
IT, TOF NACE: 12.5 mM 
HCOONH4 in MeOH 
(pHapp= 7.4) 
Aqueous: 25 mM borate 
pH 11.0 
MSn [99] 
Peptide mixture - Digestion ESI (sheath-liquid: 
MeOH-water 50:50 v/v; 
0.05 v/v HCOOH, 4 
µL/min) 





Amino acids Orange juice Derivatization with 
FITC and DNS 
ESI (sheath-liquid: 
MeOH-water 50:50 v/v 
with 25% 100 mM NH4Ac 
pH 6 5 mM β-CD; 3.5 
µL/min) 
IT 100 mM NH4Ac pH 6 5 
mM β-CD 
Capillary coating, [101] 
γ-glutamyl-S-ethenyl-
cysteine (GEC) 






MeOH-water 50:50 v/v 
0.1% v/v HOAc, 3 
µL/min) 
IT 20 mM NH4HCO3 pH 7 LOD: 0.021 mg/mL [102] 







2-propanol 75:25 v/v, 0.5 
% v/v HOAc, 6 µL/min) 
IT 40 mM ammonium 
hydrogen carbonate pH 7.8 
in water-ACN-2-propanol 
45:50:5 % v/v/v 
PLE optimization [45] 





2-propanol 75:25 v/v, 0.5 
% v/v HOAc, 6 µL/min) 
IT, TOF 40 mM ammonium 
hydrogen carbonate pH 7.8 
in water:ACN 2-propanol 
45:50:5 % v/v/v 
- [44] 
Anthocyanins Wine and wine musts SPE ESI (sheath-liquid: 
MeOH:water 80:20, 
0.25% v/v HOAc) 
IT 200 mM 
monochloroacetate-
ammonium, pH 2 or 200 
mM borate-ammnonium, 
pH 9 
Acidic and basic 
BGE. LOD: 0.8-1 .5 
mg/L (acidic); 4-10 
mg/L (basic) 
[103] 
Antidepressants Water SPE ESI (sheath-liquid: 5 mM 
HCOONH4 in 8:2 
isopropanol/water, 1  
µL/min) 
QTOF 1 .5 M HCOOH, 50 mM 
HCOONH4 in ACN/water 
85:15 
LOD: 22-280 µg/L [104] 
Basic proteins Chicken and turkey egg 






MeOH:water 50:50 v/v, 
0.05 % v/v HOAc 4 
µL/min) 
IT 75 mM NHOAc/ HOAc, 
pH 5.5 
Polymer capillary 








ICP Q 10 mM Tris-HCl pH 7.4 Speciation study; 
LOD: 1.1 µg Mn/L 
[106] 




propanol/1 M HOAc 1 :1  
v/v, 3 µL/min) 




Oxycodone phase I and II 
metabolites 
Urine SPE ESI (sheath-liquid: water-
methanol 1:1 v/v, 1% 
formic acid, 5.0 µL/min) 






Benzodiazepines Urine SPE ESI (sheath-liquid: 
MeOH-water 80:20 v/v, 2 
µL/min) 
IT 100 mM formic acid, 1  mM 
TEA 
MS2, use of 
dynamically coated 
capillaries (CEofix); 
LOD: 50-100 ppb 
[109] 
Heterocyclic amines Urine LLE-SPE ESI (sheath-liquid: 
MeOH-20 mM HCOOH 
75:25, 5 µL/min) 
IT 16 mM 
HCOOH/HCOONH4 40 
mM pH 4.5, 60% MeOH 
LOD: 0.3-45 ng/mL [25] 
Imazamox pesticide Water SPE ESI (sheath-liquid: MeOH 
HCOONH4 (5 mM) 50:50 
v/v, pH 3.7, 4 µL/min) 
IT 10 mM HCOONH4 in 
0.01% MeOH-water, pH 
7.0 
LOD: 20 ng/L [110] 
Glycosaminoglycan 
oligosaccharides 





ESI (sheathless) QTOF 50 mM NH4OAc pH 12.0 
in water:MeOH 40:60 v/v 
MS2 [111] 
Serotonin, tryptophan and 
5-hydroxytryptophan 
Plasma SPE ESI (sheath-liquid: 
MeOH/water 60:40 v/v, 
0.2% HCOOH, 2 µL/min) 
TOF 1.5% HCOOH (pH 2.07) LOD: 0.13-3.23 µM [18] 
Pesticides Fruit juices SPME ESI (sheath-liquid: 
isopropanol-water 65% 
v/v, 0.22 mL/h) 




9 biogenic amines Red and white wines FI system ESI (sheath-liquid: 70:30 
v/v MeOH/water, 1.0% 
HCOOH, 4 µL/min) 
Q 25 mM citric acid pH 2 LOD 0.018-0.09 
µg/mL 
[52] 
Pesticides Water, grape, apple, 
orange, tomato 
SPME ESI (sheath-liquid: 32 mM 
HCOONH4-HCOOH pH 
3.1  + 20% MeOH, 14 
µL/min) 
Q 32 mM HCOONH4-
HCOOH pH 3.1 
LOQ: 0.02-5 mg/Kg [39] 
Peptides and proteins Urine SPE, lyophilization ESI (sheath-liquid: 30% 
v/v MeOH, 0.5% v/v 
HCOOH, 5 µl/min) 
TOF 30% v/v MeOH, 0.5% v/v 









MeOH-water 80:20 v/v, 
0.5 % v/v HOAc, 6 
µl/min) 
IT 50 mM NH4OAc HOAc, 
pH 4 
Comparison CE-UV, 
CE-MS with LC-EC; 
LOD: 0.7-1.4 µM 
[113] 
Alkaloids Herbs (Strychnos pieman, 
Radix aconiti praeparata) 
Ultrasonication ESI (sheath-liquid: water-
MeOH 1:9 v/v, 0.5% 
HOAc, 3 µL/min) 
QIT NH4OAc, HOAc, MeOH - [30] 
Pesticides Wheat Extraction with 
water-acetone 
ESI (sheathless) IT 1 mM NH4Ac/HOAc (pH 
6.3) in MeOH:water 50:50 
v/v 
Coated capillary; 




Urine LLE, SPE ESI (sheath-liquid: 
MeOH:20 mM HCOOH 
75:25, v/v, 3 µL/min 
IT 16 mM 
HCOOH/HCOONH4, pH 
4.5, 60% MeOH 
FASI. LOD: 0.8-21  
ng/g 
[26] 
Enantiomeric drugs Plasma LLE ESI (sheath-liquid:  
ACN/5 mM 
NH4OAc/HCOOH 
75:25:0.1 (v/v), 2 µL/min) 
TOF 25% MeOH, 75% 5 mM 
NH4OAc (pH 6), 1 .0% 
HOAc, 0.3% HS-β-CD 
Electrokinetic 
injection; LOQ: 10 
ng/mL 
[114] 
Polypeptides Dialysis fluids, urine, Anion exhange ESI (sheath-liquid: 30% TOF 30% MeOH and 0.5% Polipeptide pattern [115] 
serum chromatography, 
lyophilization 
MeOH, 0.5% HCOOH, 
69.5% water, pH 2.3-2.5, 
10 µl/min) 




phenols and aromatic 
acids 
Biomass burning aerosol Filter extract (water) ESI (sheath-liquid: water 
50% 2-propanol 50% v/v, 
3 µl/min) 
IT 20 mM NH4OAc-10% 
MeOH pH 9.1; 1  M 
NH4OH pH 11  
LOD: 0.1-1.0 µM [116] 
Glycoalkaloids and 
relative aglycones 
Potatoes Extraction with 
MeOH 
ESI (sheath-liquid: 
MeOH-water 1:1 v/v, 1% 
HOAc, 2.5 µL/min) 
IT 90:10 v/v MeCN-MeOH 
containing 50 mM 
NH4OAc 1.2 M HOAc 
MS2; LOD: 10-50 
µg/L 
[117] 
Irioid glycosides Plants Water extraction ESI (sheath-liquid: 1.0 
mM lithium acetate in 
water-MeOH 50:50 v/v, 
200 µL/h) 
IT 100 mM SDS in 20 mM 
ammonium acetate, pH 9.5 







Fruits, vegetables Sonication, SPE ESI (sheath-liquid: 20 mM 
HCOOH -12 mM 
HCOONH4 pH 3.5 with 
2% MeOH, 13 µl/min) 
Q 20 mM HCOOH -12 mM 





Oxycodone and major 
metabolites 
Urine SPE, LLE ESI(sheath-liquid: water-
methanol 50:50 v/v, 1% 
formic acid, 5 µL/min 




300 ng/ml) and FASS 
(LOD: 1-50 ng/ml) 
[77] 
Catecholamines Urine SPE ESI (sheathless) QQQ Various BGE containing 
NH4OAc, water, MeOH, 
ethanol, HOAc, propanol 
LOD: 0.48-1.30 µM [20] 
Catecholamines and 
metanephrines 




TOF 1% HOAc ( pH 2.8) Electrokinetic 
injection 
[19] 
Furosemide Urine SPE ESI (sheath-liquid: 
MeOH-water-ammonia 
50:49:1 v/v, 5 µL/min) 
IT 20 mM NH4OAc pH 9 with 
TEA 
MS2 [118] 
Opioids Urine SPE, LLE ESI (sheath-liquids: 
MeOH-water 60:40 v/v, 
1% HOAc or 1% 
HCOOH, 3µl/min or 5 
µl/min) 
IT 25 mM NH4OAc pH 9 Use of FASS [76] 
Drugs River water LLE, SPE ESI (sheath-liquid: 2-
propanol-water 80:20 v/v, 
0.1% v/v HOAc or 0.1% 
v/v TEA; 4 µl/min) 
Q 20 mM NH4OAc pH 5.1 LOD: 18-134 µg/L [119] 





ethanol and HCl 
ESI (sheath-liquid: 
isopropanol-water 50:50 
v/v, 0.5% HCOOH; 
3µl/min) 
Q 25 mM NH4OAc and 1 M 
HOAc in MeOH-ACN 
20:80 v/v 
LOD: 0.05 µg/mL [120] 
Irioid glycosides Plants Water extraction ESI (sheath-liquid: 1.0 
lithium acetate in water-
MeOH 50:50 v/v, 200 
µL/h) 
IT 100 mM SDS in 20 mM 
NH4OAc, pH 9.5 
LOD: 25-50 mg/L [32] 
Morphine and related 
opiods 
Urine LLE, SPE ESI (sheath-liquid: 
MeOH:water 60:40 v/v, 
1% HOAc, 3 µl/min) 
IT 25 mM ammonium acetate 
and NH3 (pH 9) 





Serum, urine Inmunoaffinity CE ESI (sheath-liquid: 20 mM 
HOAc in 50% MeOH, 0.5 
ml/min) 
Q 60 mm NH4HCO3 pH 8.0, 
1% v/v ACN  
- [121] 
Tramadol and its main 
phase I metabolite 
Plasma LLE ESI (sheath-liquid: 
Isopropanol-water 1:1 v/v, 
0.5% formic acid, 3 
µl/min) 
Q 40 mM ammonium acetate 
buffer, pH 4.0, sulfobutyl 
ether β-CD (2.5 mg/ml) 
Partial filling [12] 
Etodolac and its urinary 
phase I metabolites 
Urine LLE ESI (sheath-liquid: ACN-
10 mM ammonium 
formate pH 3.0 1:1 v/v, 3 
µl/min) 
IT ACN-10 mM ammonium 
formate pH 3.0 1:1 v/v 






Urine SPE ESI (sheath-liquid: ACN-
20mM ammonium acetate 
1 :1  v/v, 5 µl/min) 
QQQ 20 mM ammonium acetate, 
pH 6.84 




and their glucuronides 
Urine SPE ESI (sheath-liquid: 
MeOH-water-acetic acid 
69:39:1 v/v/v, 3 µL/min) 





Urine LLE ESI (sheath-liquid: 
MeOH:water:HOAc 
60/39/1 v/v/v, 3 µL/min) 
IT 20 mM NH4OAc, 20 mM 
HOAc pH 4.6 
MS2 [123] 
Proteins - In-line digestion 
microchip 
ESI (sheathless) Q 10 mM (NH4)HCO3, 100 
mM HCOOH 
- [67] 
 
 
